Vai al contenuto

Interazioni tra farmaci

Efavirenz + Lomitapide

Gravità: Controindicata

Efavirenz and Lomitapide: contraindicated interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Lomitapide is a sensitive CYP3A4 substrate and exposure can rise markedly with interacting drugs, increasing hepatotoxicity and gastrointestinal adverse effects. Efavirenz is a mixed CYP3A4 modulator and the net effect is uncertain, but the label restricts such combinations.

Cosa significa questa interazione in parole semplici

Efavirenz and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Efavirenz belongs to Anti Virals; Lomitapide belongs to Cardiovascular.

Livello di evidenza: Low

Perché avviene

Efavirenz modulation of CYP3A4 alters lomitapide metabolism, with potential for increased exposure.

Cosa fare

Avoid the combination and choose a different lipid-lowering strategy or antiretroviral. If lomitapide is essential, monitor liver enzymes closely.

Cosa chiedere al farmacista

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Efavirenz e Lomitapide, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Efavirenz with Lomitapide?

MediHelp rates the interaction as contraindicated. Efavirenz and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Lomitapide is a sensitive CYP3A4 substrate and exposure can rise markedly with interacting drugs, increasing hepatotoxicity and gastrointestinal adverse effects. Efavirenz is a mixed CYP3A4 modulator and the net effect is uncertain, but the label restricts such combinations.

How serious is the interaction between Efavirenz and Lomitapide?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and choose a different lipid-lowering strategy or antiretroviral. If lomitapide is essential, monitor liver enzymes closely.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi